Back to top

Lake Street starts Aeon Biopharma at Buy on potential of Botox competitor

As previously reported, Lake Street initiated coverage of Aeon Biopharma (AEON) with a Buy rating and $1 price target Aeon is developing a biosimil...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

AEON Biopharma, Inc. (AEON)